TY - JOUR
AU - Cresta W. Jones
AU - Mishka Terplan
A1 - 
AB - A 25-year-old woman, gravida 3 para 2 at 12 weeks of gestation, with two prior cesarean deliveries, presents for prenatal care. She is in treatment for opioid use disorder on extended-release naltrexone injection, with a history of opioid overdose, relapse, and poor treatment adherence on methadone and buprenorphine. She asks, "Is it safe for my baby if I continue on this medication? How will you manage my postoperative pain?"
AD - Department of Obstetrics, Gynecology and Women's Health, University of Minnesota Medical School, Minneapolis, Minnesota; and Virginia Commonwealth University, Richmond, Virginia.
BT - Obstetrics and gynecology
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 4
CY - United States
DO - 10.1097/AOG.0000000000002864
IS - 4
JF - Obstetrics and gynecology
LA - eng
M1 - Journal Article
N2 - A 25-year-old woman, gravida 3 para 2 at 12 weeks of gestation, with two prior cesarean deliveries, presents for prenatal care. She is in treatment for opioid use disorder on extended-release naltrexone injection, with a history of opioid overdose, relapse, and poor treatment adherence on methadone and buprenorphine. She asks, "Is it safe for my baby if I continue on this medication? How will you manage my postoperative pain?"
PP - United States
PY - 2018
SN - 1873-233X; 0029-7844
SP - 923
EP - 925
EP - 
T1 - Pregnancy and Naltrexone Pharmacotherapy
T2 - Obstetrics and gynecology
TI - Pregnancy and Naltrexone Pharmacotherapy
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 30204703
U3 - 10.1097/AOG.0000000000002864
VL - 132
VO - 1873-233X; 0029-7844
Y1 - 2018
Y2 - Oct
ER -